Funding
Funding not disclosed
Founders
Product
Problem
Biomedical research often struggles with fragmented and heterogeneous data sourced from clinical records, laboratory equipment, biospecimens, omics assays, and imaging studies. This lack of harmonization hampers reliable analysis, slows discovery, and limits the ability to generate actionable insights into disease progression and treatment outcomes.
Solution
Jernigan provides end‑to‑end data integration services that consolidate disparate biomedical datasets into a unified, queryable format. The company designs and implements large‑scale ETL pipelines that standardize data structures, resolve inconsistencies, and enrich records with metadata. Leveraging machine‑learning techniques, Jernigan transforms the harmonized data into analytical-ready assets that reveal patterns of disease progression and treatment efficacy. The resulting data repository is reliable, accessible, and tailored for researchers to accelerate hypothesis testing and translational studies.
Target Audience
Primary customers are academic research institutions, pharmaceutical and biotech companies, and healthcare organizations that require comprehensive, high‑quality biomedical data for translational research and drug development.
Features
- Custom ETL pipelines for clinical, equipment, biospecimen, omics, and imaging data streams
- Automated data harmonization using domain ontologies and standardized vocabularies
- Scalable infrastructure to ingest and process terabytes of biomedical data
- Machine‑learning models that generate disease progression and treatment outcome insights
- Data validation and quality‑control modules ensuring consistency and reproducibility
- Secure, role‑based access to integrated datasets for research teams